This inventor holds 5 USPTO granted patents and 1 EPO patent. Top assignees: Seoul National University, The United States of America as Represented by the Department of Health, Korea Research Institute of Chemical Technology. Active years: 1997-2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:



Years Active: 1997-2009
Title: Sang-Chul Park: Innovator in Cellular Senescence
Introduction
Sang-Chul Park is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of cellular senescence, holding a total of 5 patents. His work focuses on understanding the mechanisms of cellular aging and developing methods to detect and modulate senescent cells.
Latest Patents
Among his latest patents, one invention relates to a method for detecting a senescent cell. This method involves measuring a relative alteration in a signal or molecular species involved in signal transduction compared to young cells. Additionally, he has developed a composition for modulating cellular senescence, which includes treating a senescent cell with an effective amount of an inhibitor of adenylyl cyclase or an inhibitor of protein kinase A. Another notable patent involves nucleic acid sequences and proteins associated with cellular senescence, particularly focusing on amphiphysin and caveolin.
Career Highlights
Sang-Chul Park has worked with esteemed institutions, including Seoul National University and the United States of America as represented by the Department of Health. His research has significantly advanced the understanding of cellular senescence and its implications for health and disease.
Collaborations
He has collaborated with notable colleagues such as In-Gyu Kim and Peter M Steinert, contributing to a rich exchange of ideas and research in the field.
Conclusion
Sang-Chul Park's innovative work in cellular senescence has paved the way for new methods of detection and modulation of senescent cells. His contributions are vital for advancing research in aging and related health issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile